SCHEMBL9790744

SCHEMBL9790744

O=P(O)(O)C(Nc1ncco1)P(=O)(O)O.[NaH].[NaH]

nearest known ligand 0.49

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
FDPS P14324 16/20 0.49
FDFT1 P37268 2/20 0.42
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
MMP2 P08253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9790706 0.98 FDPS (0.50) FDPSFDFT1CA12CA9MMP2
SCHEMBL9790750 0.87 FDPS (0.41) FDPSFDFT1
Phosphonic Acid SCHEMBL9790757 0.70 CSNK2A2 (0.33)
SCHEMBL9790801 0.69 CA12 (0.40) FDPSFDFT1CA12CA9MMP2
SCHEMBL15836949 0.69
SCHEMBL22660990 0.68 FFAR2 (0.43)
SCHEMBL7797073 0.67 FDPS (0.61) FDPSFDFT1CA12CA9
SCHEMBL10337554 0.67 FDPS (0.49) FDPSFDFT1CA12
SCHEMBL5156538 0.66 FDPS (1.00) FDPSFDFT1CA12CA9
SCHEMBL21048216 0.66 FFAR2 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5057505-A Treatment of illnesses attributed to calcium metabolism disorders CIBA-GEIGY CORPORATION (US) 1991-10-15 US disclosed